Similar articles

• Doxycycline, not minocycline, induces its own resistance in multidrug-resistant, community-associated methicillin-resistant Staphylococcus aureus clone USA300.

  Schwartz BS, Graber CJ, Diep BA, Basuino L, Perdreau-Remington F, Chambers HF. Schwartz BS, et al. Clin Infect Dis. 2009 May 15;48(10):1483-4. doi: 10.1086/598510. Clin Infect Dis. 2009. PMID: 19374563 No abstract available.
• Activity of tigecycline against methicillin-resistant Staphylococcus aureus (MRSA) from respiratory tract sources.

  Hawser SP. Hawser SP. Int J Antimicrob Agents. 2010 Apr;35(4):414-5. doi: 10.1016/j.ijantimicag.2009.11.023. Int J Antimicrob Agents. 2010. PMID: 20137900 No abstract available.
• Variable daptomycin susceptibility in patients receiving intravenous vancomycin for meticillin-resistant Staphylococcus aureus infections.

  Golden M, Shaib W, Havill N. Golden M, et al. Int J Antimicrob Agents. 2010 Mar;35(3):306-8. doi: 10.1016/j.ijantimicag.2009.10.022. Epub 2009 Dec 24. Int J Antimicrob Agents. 2010. PMID: 20036108 No abstract available.
• Minocycline--an old drug for a new century: emphasis on methicillin-resistant Staphylococcus aureus (MRSA) and Acinetobacter baumannii.

  Bishburg E, Bishburg K. Bishburg E, et al. Int J Antimicrob Agents. 2009 Nov;34(5):395-401. doi: 10.1016/j.ijantimicag.2009.06.021. Epub 2009 Aug 8. Int J Antimicrob Agents. 2009. PMID: 19665876 Review.
• Minocycline, often forgotten but preferred to trimethoprim-sulfamethoxazole or doxycycline for the treatment of community-acquired meticillin-resistant Staphylococcus aureus skin and soft-tissue infections.

  Cunha BA. Cunha BA. Int J Antimicrob Agents. 2013 Dec;42(6):497-9. doi: 10.1016/j.ijantimicag.2013.08.006. Epub 2013 Sep 13. Int J Antimicrob Agents. 2013. PMID: 24126085 Review.